CF1CYZZ
Planar Nuclear Medicine Imaging Hepatobiliary System, All to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | 1 Planar Nuclear Medicine Imaging |
| Body Part | C Hepatobiliary System, All |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions
Procedure Overview
Planar nuclear medicine imaging of the hepatobiliary system and pancreas centers on the hepatobiliary iminodiacetic acid (HIDA) scan, in which a radiotracer is injected intravenously, taken up by the liver, and excreted into the bile ducts, gallbladder, and small intestine. A gamma camera captures a series of flat images over roughly one to four hours as the tracer moves through this pathway, showing whether bile flows normally from the liver into the gallbladder and out into the intestine.
The scan is ordered most often to diagnose acute cholecystitis when ultrasound findings are inconclusive, since a gallbladder that fails to fill with tracer strongly suggests obstruction of the cystic duct. It is also used to evaluate biliary leaks after gallbladder surgery or liver transplant, chronic gallbladder dysfunction measured through an ejection fraction after a fatty meal or medication is given, and, less commonly, biliary atresia in infants.
Anatomy & Axis Detail
Hepatobiliary System, All
A whole hepatobiliary study captures the entire functional pathway of bile production and drainage in one continuous sequence, following tracer as hepatocytes extract it from the blood, concentrate it into bile, and pass it through the intrahepatic ducts, common bile duct, and into the duodenum. Rather than isolating a single structure, this comprehensive planar acquisition documents the timing relationships between the liver, biliary tree, gallbladder, and bowel, which is what allows differentiation between hepatocellular dysfunction, mechanical obstruction, and cystic duct occlusion. Serial images taken over an extended period, sometimes with delayed views or pharmacologic augmentation, reveal whether tracer transit is simply slow or truly blocked. Because the entire system is imaged together, this approach is favored when the clinical question involves the biliary tract broadly rather than a single organ in isolation.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
Coding relies on the report confirming a single-plane, sequential imaging technique rather than a tomographic reconstruction, along with the radioisotope used, typically a technetium-99m labeled iminodiacetic acid derivative. When the study includes a pharmacologic or fatty-meal challenge to calculate a gallbladder ejection fraction, that is part of the same study and does not generate a separate code. A recurring mistake is coding delayed imaging performed hours after the initial injection as a distinct procedure, when it is a continuation of the same planar study and should be captured with a single code.
Commonly Confused With
The main distinction to watch for is Tomographic (Tomo) Nuclear Medicine Imaging of the hepatobiliary system, which would apply only if the camera rotated to build cross-sectional images, something uncommon for standard HIDA protocols but occasionally used for complex biliary anatomy. It is also sometimes confused with liver-spleen scans or sulfur colloid studies that assess liver parenchyma rather than biliary excretion; the tracer type and the structures the report describes as being evaluated, biliary tree versus liver tissue itself, separate the two.